These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25457818)

  • 81. Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.
    Hanna-Pladdy B; Enslein A; Fray M; Gajewski BJ; Pahwa R; Lyons KE
    Int J Neurosci; 2010 Aug; 120(8):538-43. PubMed ID: 20615057
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cognitive reserve and β-amyloid pathology in Parkinson disease.
    Lucero C; Campbell MC; Flores H; Maiti B; Perlmutter JS; Foster ER
    Parkinsonism Relat Disord; 2015 Aug; 21(8):899-904. PubMed ID: 26037458
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Weintraub D; Antonini A
    Mov Disord; 2015 Apr; 30(5):688-95. PubMed ID: 25649923
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anatomical correlates of cognitive functions in early Parkinson's disease patients.
    Biundo R; Calabrese M; Weis L; Facchini S; Ricchieri G; Gallo P; Antonini A
    PLoS One; 2013; 8(5):e64222. PubMed ID: 23717572
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Applause sign in advanced Parkinson's disease.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1268-9. PubMed ID: 25260968
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns.
    Abu Snineh M; Camicioli R; Miyasaki JM
    Parkinsonism Relat Disord; 2017 Jun; 39():77-79. PubMed ID: 28336349
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Precuneal Thickness and Depression in Parkinson Disease.
    Zanigni S; Sambati L; Evangelisti S; Testa C; Calandra-Buonaura G; Manners DN; Terlizzi R; Poda R; Oppi F; Lodi R; Cortelli P; Tonon C;
    Neurodegener Dis; 2017; 17(2-3):97-102. PubMed ID: 27883992
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Focal cortical and subcortical atrophy in early Parkinson's disease.
    Tinaz S; Courtney MG; Stern CE
    Mov Disord; 2011 Feb; 26(3):436-41. PubMed ID: 21462259
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease.
    Nocera JR; Price C; Fernandez HH; Amano S; Vallabhajosula S; Okun MS; Hwynn N; Hass CJ
    Parkinsonism Relat Disord; 2010 Nov; 16(9):590-4. PubMed ID: 20829093
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Firbank MJ; Parikh J; Murphy N; Killen A; Allan CL; Collerton D; Blamire AM; Taylor JP
    Neurology; 2018 Aug; 91(7):e675-e685. PubMed ID: 30021920
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cortical thinning in drug-naive Parkinson's disease patients with depression.
    Luo C; Song W; Chen Q; Yang J; Gong Q; Shang HF
    J Neurol; 2016 Oct; 263(10):2114-9. PubMed ID: 27485171
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Global cortical atrophy may be associated with fatigue in patients with parkinson's disease.
    Lu ZH; Chen YK; Fu XL; Liu YL; Qu JF; Xiao WM
    J Clin Neurosci; 2020 Sep; 79():172-177. PubMed ID: 33070891
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Wang L; Nie K; Zhao X; Feng S; Xie S; He X; Ma G; Wang L; Huang Z; Huang B; Zhang Y; Wang L
    Neurosci Lett; 2018 Apr; 673():85-91. PubMed ID: 29275185
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Deng X; Tang CY; Zhang J; Zhu L; Xie ZC; Gong HH; Xiao XZ; Xu RS
    Neurosci Lett; 2016 Oct; 633():279-289. PubMed ID: 27721206
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Substantia innominata: MR findings in Parkinson's disease.
    Oikawa H; Sasaki M; Ehara S; Abe T
    Neuroradiology; 2004 Oct; 46(10):817-21. PubMed ID: 15316699
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Olfactory Function, Eating Ability, and Visceral Obesity Associated with MMSE Three Years after Parkinson's Disease Diagnosis.
    Vikdahl M; Domellöf ME; Forsgren L; Håglin L
    J Nutr Health Aging; 2015 Nov; 19(9):894-900. PubMed ID: 26482690
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cognitive and motor dysfunction in Parkinson's disease. Clinical, performance, and computed tomographic correlations.
    Lichter DG; Corbett AJ; Fitzgibbon GM; Davidson OR; Hope JK; Goddard GV; Sharples KJ; Pollock M
    Arch Neurol; 1988 Aug; 45(8):854-60. PubMed ID: 3293555
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Attentional functions in multiple system atrophy and Parkinson's disease.
    Meco G; Gasparini M; Doricchi F
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):393-8. PubMed ID: 8774403
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Memory impairment in occipital periventricular hyperintensity patients is associated with reduced functional responses in the insula and Heschl's gyrus.
    Duan D; Shen L; Li C; Cui C; Shu T; Zheng J
    Int J Neurosci; 2017 Jun; 127(6):493-500. PubMed ID: 27323873
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mini mental Parkinson test: standardization and normative data on an Italian sample.
    Costa A; Bagoj E; Monaco M; Zabberoni S; De Rosa S; Mundi C; Caltagirone C; Carlesimo GA
    Neurol Sci; 2013 Oct; 34(10):1797-803. PubMed ID: 23479031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.